Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 1/7/2026

Causes of Sudden Onset of Dyspnea During Hemodialysis

Cardiovascular Causes

  • The American College of Cardiology notes that myocardial ischemia is a frequent serious cause of dyspnea during hemodialysis, often induced by hypotension or tachyarrhythmias in patients with coronary artery disease 1, 2
  • The American Journal of Kidney Diseases recommends that fluid overload, which can lead to pulmonary congestion and dyspnea, be managed through adequate ultrafiltration or correct dry weight assessment 3, 4
  • Arrhythmias triggered by electrolyte shifts during dialysis can cause dyspnea, according to Circulation 5
  • Pericarditis is a potential complication in dialysis patients that can present with dyspnea, as noted by the American College of Cardiology 1
  • Rapid ultrafiltration can cause hypotension and compensatory dyspnea, as reported by the American Journal of Kidney Diseases 6

Pulmonary Causes

  • The American College of Cardiology states that pulmonary embolism is a cause of sudden dyspnea during hemodialysis, particularly with inadequate anticoagulation 1
  • Pulmonary hypertension can worsen during dialysis due to fluid shifts, according to the American Journal of Kidney Diseases 3

Other Causes

  • Electrolyte imbalances can trigger respiratory muscle dysfunction and dyspnea, as noted by the American Journal of Kidney Diseases 6
  • The American Journal of Kidney Diseases and Praxis Medical Insights agree that anemia can reduce oxygen-carrying capacity and worsen during dialysis 6, 7

Diagnostic Approach

  • The American College of Cardiology recommends immediate assessment of vital signs, including oxygen saturation, in cases of dyspnea during hemodialysis 1
  • The American Journal of Kidney Diseases suggests examining for signs of fluid overload, such as crackles or elevated jugular venous pressure 3
  • A 12-lead ECG should be performed to evaluate for ischemia or arrhythmias, as recommended by the American College of Cardiology 1, 2
  • A chest X-ray can help identify pulmonary edema, infiltrates, or pneumothorax, according to the American Journal of Kidney Diseases 4

Management Principles

  • For suspected cardiac ischemia, the American College of Cardiology recommends obtaining an ECG immediately and transferring the patient to an acute care setting by EMS 1, 2
  • The American Journal of Kidney Diseases suggests adjusting ultrafiltration goals and reassessing dry weight for fluid overload 3, 4

Prevention Strategies

  • Regular assessment of dry weight and cardiovascular status can help prevent dyspnea during hemodialysis, as recommended by the American Journal of Kidney Diseases 3, 4
  • Appropriate anticoagulation during dialysis can prevent pulmonary embolism, according to the American College of Cardiology 1
  • Slower ultrafiltration rates can help prevent dyspnea in patients with cardiovascular instability, as suggested by the American Journal of Kidney Diseases and Praxis Medical Insights 6, 7

Management of Post‑Dialysis Dyspnea in Hemodialysis Patients

Diagnostic Evaluation

  • Obtain an urgent 12‑lead electrocardiogram to rule out myocardial ischemia or arrhythmias, especially in patients with known coronary risk factors. 8
  • Measure BNP or NT‑proBNP promptly; a level >200 pg/mL in dialysis patients strongly suggests a cardiac origin of dyspnea. 9

Cardiovascular Causes

  • Myocardial ischemia is a common trigger of dyspnea during or after dialysis, often precipitated by intradialytic hypotension or rhythm disturbances in patients with coronary artery disease. 8
  • Persistent volume overload—resulting from inadequate ultrafiltration or an incorrectly set dry weight—can lead to pulmonary congestion and acute dyspnea. 10

Acute Management of Suspected Cardiac Ischemia

  • Transfer the patient immediately to an acute‑care setting with continuous cardiac monitoring. 8
  • Prioritize urgent percutaneous coronary intervention (PCI) over thrombolysis, because dialysis patients have a markedly increased risk of bleeding with thrombolytic therapy. 8
  • Administer aspirin, beta‑blockers, and consider GPIIb/IIIa inhibitors (e.g., abciximab) without dose adjustment for the dialysis population. 8

Management of Confirmed Volume Overload

  • Re‑evaluate and aggressively lower the target dry weight over a period of 4–12 weeks (potentially extending to 6–12 months in diabetic patients) to achieve euvolemia. 10
  • Implement strict dietary sodium restriction (≈2–3 g per day) with regular dietitian follow‑up to support volume control. 10

Interpretation of Cardiac Biomarkers

  • Recognize that baseline troponin concentrations are often elevated in dialysis patients; diagnosis of acute ischemia should rely on dynamic changes rather than absolute values. 8

REFERENCES

7

Management of Hypotension During Hemodialysis [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025